Clinical Trials
3 trialsNCT05036434 2026-01-23
ACCOMPLISH
National Cancer Center, Korea
Phase 2 Active not recruiting
NCT05832827 2023-10-23
Artemis
National Cancer Center, Japan
Phase 2 Recruiting
NCT04519151 2023-06-08
Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer
Sheba Medical Center
Phase 2 Recruiting